Haji Ali Sazan, Osmaniye Derya, Sağlık Begüm Nurpelin, Levent Serkan, Özkay Yusuf, Kaplancıklı Zafer Asım
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hawler Medical University, Erbil 44000, Iraq.
Graduate Education Institute, Anadolu University, Eskişehir 26470, Turkey.
ACS Omega. 2024 Sep 16;9(38):39326-39343. doi: 10.1021/acsomega.3c07879. eCollection 2024 Sep 24.
In this study, a series of novel thiazol-2(3)-imine (-) were designed, synthesized, and characterized by means of H NMR, C NMR, and HRMS spectral analyses. In vitro antifungal activity was performed using a modified EUCAST protocol. Two of the synthesized compounds ( and ) showed activity against and . Compound showed activity against (MIC = 1.23 μg/mL) for 48 h. This value is very similar to ketoconazole. The dynamic analysis of the potential compounds and revealed notable stability while interacting with the 14α-demethylase enzyme substrate. The absorption, distribution, metabolism, and excretion (ADME) studies of the candidate compound showed acceptable ADME parameter data and verified their drug-likeness characteristics. According to the results of this study, compound 4-(4-fluorophenyl)--(3-morpholinopropyl)-3-phenylthiazol-2(3)-imine () and its derivatives as 14α-demethylase inhibitors can be used as a new antifungal for further structural improvements and additional research.
在本研究中,设计、合成了一系列新型噻唑 - 2(3)-亚胺(-),并通过氢核磁共振(¹H NMR)、碳核磁共振(¹³C NMR)和高分辨质谱(HRMS)光谱分析对其进行了表征。使用改良的欧洲抗菌药物敏感性试验委员会(EUCAST)方案进行体外抗真菌活性检测。所合成的两种化合物( 和 )对 和 显示出活性。化合物 对 (最小抑菌浓度(MIC)= 1.23 μg/mL)在48小时内显示出活性。该值与酮康唑非常相似。对潜在化合物 和 的动力学分析表明,它们在与14α - 脱甲基酶底物相互作用时具有显著的稳定性。候选化合物的吸收、分布、代谢和排泄(ADME)研究显示出可接受的ADME参数数据,并证实了它们的类药特性。根据本研究结果,化合物4 - (4 - 氟苯基)- - (3 - 吗啉丙基)-3 - 苯基噻唑 - 2(3)-亚胺( )及其衍生物作为14α - 脱甲基酶抑制剂可作为新型抗真菌剂用于进一步的结构优化和深入研究。